Articles with "mab chinese" as a keyword



Photo by nci from unsplash

Gls-010, a novel anti-PD-1 mAb in Chinese patients with recurrent or metastatic cervical cancer: Results from a multicenter, open-label and single-arm phase II trial.

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2020.38.15_suppl.6032

Abstract: 6032Background: GLS-010 is a novel fully human anti-PD-1 mAb. Previous Phase I study exhibited favorable result of tolerance, preliminary efficacy and 240mg fixed dose q2w was selected as Recommend... read more here.

Keywords: anti mab; 010 novel; phase; gls 010 ... See more keywords